EUVIMEDEUVIMED entdecken
Crossref

With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile

John Fracchia

The Journal of Community and Supportive Oncology · 2013

DOI: 10.12788/j.cmonc.0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2013. Verfasst von John Fracchia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fracchia, J. (2013). With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.cmonc.0012

Vancouver

Fracchia J. With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile. The Journal of Community and Supportive Oncology. 2013. doi:10.12788/j.cmonc.0012

BibTeX
@article{Fracchia2013,
  author = {Fracchia, John},
  title = {With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile},
  journal = {The Journal of Community and Supportive Oncology},
  year = {2013},
  doi = {10.12788/j.cmonc.0012}
}
Kostenlos starten →